Cancer immunotherapy 2025: Types, benefits, risks, cost, diet and efficacy in stage 4 cancer! скачать в хорошем качестве

Cancer immunotherapy 2025: Types, benefits, risks, cost, diet and efficacy in stage 4 cancer!

Immunotherapy has been revolutionizing cancer treatment for the past 15 years. Cancer immunotherapy includes options such as checkpoint blockers, CAR-T cell therapy, adoptive cell transfer, cancer vaccines, cytokines, oncolytic viruses, TIL therapy, bispecific T-cell engagers (BiTE), and BCG therapy. It helps the immune system fight cancer, and is proving to be a ray of hope for patients with stage 1, stage 2, stage 3, and stage 4 cancers such as lung, breast, thyroid, brain, bladder, liver, bone, mouth, pancreas, colon, stomach, esophagus, skin, and melanoma cancers. Common checkpoint inhibitors include nivolumab (Opdivo), ipilimumab (Yervoy), pembrolizumab (Keytruda), durvalumab (Imfinzi), dostarlimab (Jemperli), and tremelumumab (Imjudo), which target proteins such as CTLA4 and PD1. These therapies have shown promising results, but they come with a risk of immune-related adverse events (IRAEs) such as fatigue, swelling, and other complications. Over the past five years, the cost of immunotherapy has dropped substantially, making it affordable for the common man today. Low-dose immunotherapy and patient support programs have made it more affordable, especially in India, where these treatments were previously considered very expensive. Benefits include increased survival rates in some cases, especially in stage 4. Addition of the right diet and lifestyle can improve overall treatment outcomes, although options such as Ayurveda should only be adopted along with modern medicine. Vaccines, interleukin and interferon therapies also play a role, but safety and effectiveness depend on the type of cancer and individual factors. Understanding cost, risk and availability is very important to make the right decision. Patients can also get the most advanced immunotherapy for free by participating in cancer research and clinical trials. Learn from Delhi's renowned Cancer Specialist Medical Oncologist Dr. Vineet Govinda Gupta MBBS (AIIMS) , MD (AIIMS), DM (AIIMS), Gold Medalist. If you have any question other than this video contact us on whatsapp, phone, or email. Subscribe to our channel. Phone: +919013812875, +917290928042 Website: http://drvineetgovinda.com E-Mail: [email protected] Facebook: @drvineetgovindagupta Twitter: @drvineetgovinda 00:00 Introduction परिचय 01:26 What is cancer immunotherapy कैंसर इम्यूनोथेरेपी क्या है 04:02 Advantages of immunotherapy इम्यूनोथेरेपी के फ़ायदे 06:07 Problems with immunotherapy इम्यूनोथेरेपी की समस्याएँ 09:08 Checkpoint blockers चेकपॉइंट ब्लॉकर्स 13:11 Cytokine therapy साइटोकाइन थेरेपी 14:36 Bispecific T-cell Engager बाइस्पेसिफिक टी-सेल एंगेजर 17:05 CAR-T cell therapy CAR-T सेल थेरेपी 18:31 Oncolytic Virus therapy ऑन्कोलिटिक वायरस थेरेपी 20:04 Adoptive cell therapy and TIL therapy एडॉप्टिव सेल थेरेपी और TIL थेरेपी 21:23 Cancer Vaccine कैंसर वैक्सीन 22:17 BCG cancer immunotherapy बीसीजी कैंसर इम्यूनोथेरेपी 24:54 Side effects and risks of immunotherapy इम्यूनोथेरेपी के दुष्प्रभाव और जोखिम 25:31 Cost of cancer immunotherapy in India भारत में कैंसर इम्यूनोथेरेपी की लागत 26:57 Diet and lifestyle for immunotherapy इम्यूनोथेरेपी के लिए आहार और जीवनशैली 28:25 Contact information संपर्क